Diabetic cystopathy--a risk factor in diabetic nephropathy?

Area of Science:

• Nephrology
• Urology
• Endocrinology

Background:

• Diabetic nephropathy is a common complication of Type I diabetes.
• Bladder dysfunction, including urinary retention, can occur in diabetic patients.
• Noninvasive assessment of bladder function is crucial for managing diabetic complications.

Purpose of the Study:

• To investigate the prevalence and characteristics of abnormal residual urine volumes in patients with Type I diabetes and diabetic nephropathy.
• To assess the correlation between residual urine volumes and the progression of renal insufficiency.
• To evaluate the effectiveness of voiding instructions in managing abnormal residual urine volumes.

Main Methods:

• Repeated noninvasive testing of residual urine volumes in 27 patients with Type I diabetes and diabetic nephropathy (mean 6 tests per patient).
• Analysis of results for abnormal residual volumes (>15 ml and >100 ml).
• Correlation analysis with renal insufficiency progression and assessment of voiding instructions' impact over a mean 32-month observation period.

Main Results:

• Abnormal residual urine volumes (>15 ml) were found in 27% of investigations (43/162).
• Significant residual volumes (>100 ml) were observed in 7% of investigations (12/162).
• Residual volumes varied within individuals and did not consistently correlate with renal insufficiency progression; voiding instructions were given to 16 patients.

Conclusions:

• Abnormal residual urine volumes are prevalent in patients with Type I diabetes and diabetic nephropathy.
• Noninvasive screening for residual urine and provision of voiding instructions are recommended for all patients with long-standing Type I diabetes.
• These interventions may help prevent acute urinary retention and bladder atony.